- Home
- DRS vs QGEN Comparison
DRS vs QGEN Comparison
Compare DRS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRS | QGEN |
|---|---|---|
| Founded | 1969 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.2B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | DRS | QGEN |
|---|---|---|
| Price | $34.23 | $44.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $46.83 | ★ $50.07 |
| AVG Volume (30 Days) | 849.5K | ★ 1.1M |
| Earning Date | 02-19-2026 | 02-04-2026 |
| Dividend Yield | 1.06% | ★ 3.36% |
| EPS Growth | 33.93 | ★ 331.20 |
| EPS | 0.99 | ★ 1.84 |
| Revenue | ★ $3,569,000,000.00 | $2,070,781,000.00 |
| Revenue This Year | $11.94 | $7.07 |
| Revenue Next Year | $6.66 | $6.14 |
| P/E Ratio | $34.46 | ★ $24.46 |
| Revenue Growth | ★ 12.27 | 5.32 |
| 52 Week Low | $28.17 | $37.63 |
| 52 Week High | $49.31 | $51.88 |
Technical Indicators
Market Signals| Indicator | DRS | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 41.56 |
| Support Level | $33.89 | $45.13 |
| Resistance Level | $34.45 | $46.02 |
| Average True Range (ATR) | 0.66 | 0.59 |
| MACD | 0.16 | -0.06 |
| Stochastic Oscillator | 63.67 | 21.39 |
Price Performance
Historical ComparisonAbout DRS Leonardo DRS Inc.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).